Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-009888
Filing Date
2019-11-05
Accepted
2019-11-05 07:39:17
Documents
89
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20190930x10q52dbde.htm   iXBRL 10-Q 2086699
2 EX-10.1 ex-10d1.htm EX-10.1 783683
3 EX-10.2 ex-10d2.htm EX-10.2 47903
4 EX-31.1 ex-31d1.htm EX-31.1 18195
5 EX-31.2 ex-31d2.htm EX-31.2 18227
6 EX-32.1 ex-32d1.htm EX-32.1 13844
  Complete submission text file 0001558370-19-009888.txt   9088119

Data Files

Seq Description Document Type Size
7 EX-101.SCH bpmc-20190930.xsd EX-101.SCH 60694
8 EX-101.CAL bpmc-20190930_cal.xml EX-101.CAL 64362
9 EX-101.DEF bpmc-20190930_def.xml EX-101.DEF 217417
10 EX-101.LAB bpmc-20190930_lab.xml EX-101.LAB 517607
11 EX-101.PRE bpmc-20190930_pre.xml EX-101.PRE 426495
65 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20190930x10q52dbde_htm.xml XML 1445701
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 191191772
SIC: 2834 Pharmaceutical Preparations